CGON
Price
$40.94
Change
-$0.67 (-1.61%)
Updated
Dec 12 closing price
Capitalization
3.3B
Intraday BUY SELL Signals
LXEO
Price
$9.77
Change
-$0.03 (-0.31%)
Updated
Dec 12 closing price
Capitalization
713.09M
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs LXEO

Header iconCGON vs LXEO Comparison
Open Charts CGON vs LXEOBanner chart's image
CG Oncology
Price$40.94
Change-$0.67 (-1.61%)
Volume$411.46K
Capitalization3.3B
Lexeo Therapeutics
Price$9.77
Change-$0.03 (-0.31%)
Volume$681.92K
Capitalization713.09M
CGON vs LXEO Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
LXEO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. LXEO commentary
Dec 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and LXEO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 15, 2025
Stock price -- (CGON: $41.61 vs. LXEO: $9.80)
Brand notoriety: CGON and LXEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 51% vs. LXEO: 52%
Market capitalization -- CGON: $3.3B vs. LXEO: $713.09M
CGON [@Biotechnology] is valued at $3.3B. LXEO’s [@Biotechnology] market capitalization is $713.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, both CGON and LXEO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 4 TA indicator(s) are bullish while LXEO’s TA Score has 6 bullish TA indicator(s).

  • CGON’s TA Score: 4 bullish, 5 bearish.
  • LXEO’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than CGON.

Price Growth

CGON (@Biotechnology) experienced а -6.98% price change this week, while LXEO (@Biotechnology) price change was +7.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($3.3B) has a higher market cap than LXEO($713M). LXEO YTD gains are higher at: 48.936 vs. CGON (45.084). LXEO has higher annual earnings (EBITDA): -102.69M vs. CGON (-179.53M). CGON has more cash in the bank: 680M vs. LXEO (123M). CGON has less debt than LXEO: CGON (7.24M) vs LXEO (8.46M). CGON has higher revenues than LXEO: CGON (2.17M) vs LXEO (0).
CGONLXEOCGON / LXEO
Capitalization3.3B713M463%
EBITDA-179.53M-102.69M175%
Gain YTD45.08448.93692%
P/E RatioN/AN/A-
Revenue2.17M0-
Total Cash680M123M553%
Total Debt7.24M8.46M86%
TECHNICAL ANALYSIS
Technical Analysis
CGONLXEO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 5 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
LXEO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBSNX30.390.24
+0.80%
William Blair Small Cap Growth N
CMIEX14.870.07
+0.47%
Multi-Manager Intl Eq Strats Instl
FRISX100.350.44
+0.44%
Franklin Rising Dividends R6
FSSGX13.64N/A
N/A
Fidelity SAI Sustainable Em Markets Eq
BIREX14.85-0.06
-0.40%
BlackRock Real Estate Securities Instl

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-0.31%
SYRE - CGON
58%
Loosely correlated
-0.87%
IDYA - CGON
57%
Loosely correlated
-0.24%
RVMD - CGON
56%
Loosely correlated
+0.81%
NUVL - CGON
56%
Loosely correlated
+0.16%
XNCR - CGON
54%
Loosely correlated
-0.58%
More

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with CLDX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
+0.72%
CLDX - LXEO
42%
Loosely correlated
-0.89%
CGON - LXEO
42%
Loosely correlated
-0.31%
RGNX - LXEO
41%
Loosely correlated
-1.61%
BEAM - LXEO
41%
Loosely correlated
+0.40%
TSHA - LXEO
41%
Loosely correlated
+3.60%
More